Skip to Main Content

Paper Details

Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2.
Open Forum Infect Dis
1
2022
Baricitinib, COVID, COVID-19, Patients, baricitinib, coronavirus disease, oxygen, participants, patient, patients, remdesivir
Author NameAffiliation
Pablo TebasDivision of Infectious Diseases/Clinical Trials Unit, University of Pennsylvania
Vincent C MarconiEmory University School of Medicine and Rollins School of Public Health, Atlanta Veterans Affairs Medical Center
Pauline K ParkUniversity of Michigan ann arbor
Aneesh K MehtaEmory University School of Medicine
Aneesh K MehtaEmory University School of Medicine
  • 1 - 5

Datasets

Release 1.2